Publications:

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: KDR: D814V

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association

Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H

Publication Date: 2020-07

Variant appearance in text: KDR: D814V

PubMed Link: 32107691

Variant Present in the following documents:

• 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12

View BVdb publication page

---

Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Drug Design, Development And Therapy

Abbaspour Babaei, Maryam M; Kamalidehghan, Behnam B; Saleem, Mohammad M; Huri, Hasniza Zaman HZ; Ahmadipour, Fatemeh F

Publication Date: 2016

Variant appearance in text: VEGFR: Asp814Val

PubMed Link: 27536065

Variant Present in the following documents:

• dddt-10-2443.pdf

View BVdb publication page

---

Hydroxyindole carboxylic acid-based inhibitors for receptor-type protein tyrosine protein phosphatase beta.

Antioxidants & Redox Signaling

Zeng, Li-Fan LF; Zhang, Ruo-Yu RY; Bai, Yunpeng Y; Wu, Li L; Gunawan, Andrea M AM; Zhang, Zhong-Yin ZY

Publication Date: 2014-05-10

Variant appearance in text: VEGFR: D814V

PubMed Link: 24180557

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.

Expert Opinion On Investigational Drugs

Harris, Pamela Jo PJ; Bible, Keith C KC

Publication Date: 2011-10

Variant appearance in text: VEGFR: D814V

PubMed Link: 21910667

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis.

Cancer

Quintás-Cardama, Alfonso A; Jain, Nitin N; Verstovsek, Srdan S

Publication Date: 2011-12-15

Variant appearance in text: KDR: D814V

PubMed Link: 21692073

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.

Plos One

Dubreuil, Patrice P; Letard, Sébastien S; Ciufolini, Marco M; Gros, Laurent L; Humbert, Martine M; Castéran, Nathalie N; Borge, Laurence L; Hajem, Bérengère B; Lermet, Anne A; Sippl, Wolfgang W; Voisset, Edwige E; Arock, Michel M; Auclair, Christian C; Leventhal, Phillip S PS; Mansfield, Colin D CD; Moussy, Alain A; Hermine, Olivier O

Publication Date: 2009-09-30

Variant appearance in text: VEGFR2: D814V

PubMed Link: 19789626

Variant Present in the following documents:

• pone.0007258.pdf

View BVdb publication page

---

Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

British Journal Of Pharmacology

Jensen, B M BM; Akin, C C; Gilfillan, A M AM

Publication Date: 2008-08

Variant appearance in text: VEGFR: D814V

PubMed Link: 18500355

Variant Present in the following documents:

• Main text

View BVdb publication page

---